Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, reported its financial results for its 2009 fiscal year (FY09) ended August 31, 2009. Ms. Momoko Beran, chief financial officer of Simulations Plus, stated: “Fourth quarter fiscal year 2009 (4Q09) consolidated revenues were $1,840,000, an increase of 0.2% or $3,600 [...]

Continue reading " Simulations Plus Reports FY2009 Financial Results "

Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of software for pharmaceutical discovery and development, announced that it expects to file its 10K-SB annual report with the Securities and Exchange Commission on Monday, November 30, for the 2009 fiscal year ended August 31, 2009. Chairman and CEO Walt Woltosz will host a conference call and webinar [...]

Continue reading " Simulations Plus Sets Date for Fiscal Year 2009 Earnings Release and Conference Call "